News

La tasa de homicidios en México aumentó tan drásticamente entre 2005 y 2015 que compensó parcialmente los aumentos esperados en la esperanza de vida entre los hombres, según un nuevo estudio realizado por un investigador de salud pública de la UCLA.

The murder rate in Mexico increased so dramatically between 2005 and 2015 that it partially offset expected gains in life expectancy among men there, according to a new study by a UCLA public health researcher.

In a recent opinion piece published in The Hill, Dr. Jonathan Fielding, distinguished professor of health policy and management at the UCLA Fielding School of Public Health, discusses causes of foodborne illnesses, and the need to eradicate this public health threat.

Most studies have focused on older women, but breast cancer can take decades to develop, and children may be most susceptible to the effects of diet, chemicals and other factors.

Numerous studies from countries around the globe have shown that education before primary school is associated with success in school. Despite this, few governments make pre-primary education available on a tuition-free basis for two or more years, according to a new study from the UCLA Fielding School of Public Health’s WORLD Policy Analysis Center (WORLD).

The six-year-long study about endocrine treatment was co-authored by FSPH professors Dr. Patricia Ganz and Catherine Crespi.

UCLA Fielding School of Public Health faculty members Ronald Hays, Steve Horvath, Michael Jerrett, André Nel, Beate Ritz and Marc Suchard have been named to Clarivate Analytics' annual list of highly cited researchers.

In a recent opinion piece published in The Hill, Dr. Jonathan Fielding, distinguished professor of health policy and management at the UCLA Fielding School of Public Health, points out the lack of evidence behind health claims associated with marijuana.

Ronald S. Brookmeyer, UCLA Fielding School of Public Health professor of biostatistics, has been appointed interim dean of the Fielding School. He will begin his term on November 1, 2018.

The study, led by Dr. Patricia Ganz, director of prevention and control research at the UCLA Jonsson Comprehensive Cancer Center and a distinguished professor at the UCLA Fielding School of Public Health, followed women with early-stage breast cancer for up to six years after they had completed their primary cancer treatments.